MDGL - Madrigal Pharmaceuticals Inc
IEX Last Trade
247.64
-1.080 -0.436%
Share volume: 203,776
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$248.72
-1.08
-0.43%
Fundamental analysis
21%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
15%
Performance
5 Days
-2.22%
1 Month
-11.74%
3 Months
9.60%
6 Months
-2.79%
1 Year
38.77%
2 Year
274.78%
Key data
Stock price
$247.64
DAY RANGE
N/A - $251.24
52 WEEK RANGE
$119.76 - $299.98
52 WEEK CHANGE
$0.33
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: Rebecca Taub
Region: US
Website: http://www.madrigalpharma.com/
Employees: 93
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.madrigalpharma.com/
Employees: 93
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.
Recent news